Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
BLFS

BIOLIFE SOLUTIONS (BLFS) stock: insider trades, news & valuation

Heavy selling
Close · Oct 7, 2026 $38.61 — on the day +0.0% over 12 months 52-week range $38.61 – $38.61

Share price and insider trades

BLFS closeInsider buyInsider sale

Price history unavailable.

Bought, 12 months$0
Sold, 12 months$56.6M
Insiders buying0
Insiders selling11

BIOLIFE SOLUTIONS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 11 sold $56.6M of BLFS stock on the open market.

BLFS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $26.4M sold (31 trades)Q4 2025Q1 2026: $2.1M sold (14 trades)Q1 2026Q2 2026: $28.1M sold (3 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$28.1M3
Q1 2026—0$2.1M14
Q4 2025—0$26.4M31

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day—Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 BIOLIFE SOLUTIONS INC insiders reported open-market purchases totaling $0, while 11 insiders reported sales totaling $56.6M. Among insiders with enough purchase history to measure, Casdin Partners Master Fund, L.P. (10% Owner) has the highest Insider Score at 87. 33 of 49 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
May 21SEC Casdin Partners Master Fund, L.P.10% Owner Sell 650,0004,757,165 held (−12%) $23.70 $15.4M — 87
May 21SEC Casdin Partners Master Fund, L.P.10% Owner Sell 300,0005,657,165 held (−5%) $22.65 $6.8M — 87
May 21SEC Casdin Partners Master Fund, L.P.10% Owner Sell 250,0005,407,165 held (−4%) $23.70 $5.9M — 87
Mar 31SEC Karen A. FosterChief Quality And Operations Sell Plan 2,577108,758 held (−2%) $19.17 $49K — —
Mar 9SEC Karen A. FosterChief Quality And Operations Sell 96,923113,742 held (−46%) $20.15 $2.0M — —
Mar 9SEC Karen A. FosterChief Quality And Operations Sell 500113,242 held (−0%) $20.00 $10K — —
Mar 5SEC Troy WichtermanCFO Sell Plan 588220,649 held (−0%) $20.74 $12K — —
Mar 5SEC Aby J. MathewEvp & Chief Scientific Officer Sell Plan 529392,937 held (−0%) $20.74 $11K — —
Mar 5SEC Karen A. FosterChief Quality And Operations Sell Plan 418210,665 held (−0%) $20.74 $9K — —
Mar 5SEC Todd BerardChief Marketing Officer Sell Plan 353165,940 held (−0%) $20.74 $7K — —
Mar 5SEC Sarah AebersoldChief Human Resources Officer Sell Plan 21993,360 held (−0%) $20.74 $5K — —
Mar 5SEC Sean WernerCTO Sell Plan 11149,932 held (−0%) $20.74 $2K — —
Jan 8SEC Troy WichtermanCFO Sell Plan 990150,746 held (−1%) $25.59 $25K — —
Jan 8SEC Aby J. MathewEvp & Chief Scientific Officer Sell Plan 405349,350 held (−0%) $25.59 $10K — —
Jan 8SEC Todd BerardChief Marketing Officer Sell Plan 344132,564 held (−0%) $25.59 $9K — —
Jan 8SEC Karen A. FosterChief Quality And Operations Sell Plan 335191,984 held (−0%) $25.59 $9K — —
Jan 8SEC Sarah AebersoldChief Human Resources Officer Sell Plan 24175,765 held (−0%) $25.59 $6K — —
Dec 17SEC Amy DurossDirector Sell 2,00018,687 held (−10%) $24.60 $49K — —
Dec 17SEC Troy WichtermanCFO Sell Plan 1,033151,736 held (−1%) $25.13 $26K — —
Dec 17SEC Sarah AebersoldChief Human Resources Officer Sell Plan 71376,006 held (−1%) $24.46 $17K — —
Dec 17SEC Aby J. MathewEvp & Chief Scientific Officer Sell Plan 631349,755 held (−0%) $25.13 $16K — —
Dec 17SEC Karen A. FosterChief Quality And Operations Sell Plan 519192,319 held (−0%) $25.13 $13K — —
Dec 17SEC Todd BerardChief Marketing Officer Sell Plan 358132,908 held (−0%) $25.13 $9K — —
Dec 17SEC Sarah AebersoldChief Human Resources Officer Sell Plan 23376,719 held (−0%) $25.13 $6K — —
Dec 5SEC Troy WichtermanCFO Sell 30,000152,769 held (−16%) $25.72 $772K — —
Nov 28SEC Amy DurossDirector Sell 2,00022,687 held (−8%) $27.00 $54K — —
Nov 28SEC Amy DurossDirector Sell 2,00020,687 held (−9%) $27.00 $54K — —
Nov 28SEC Troy WichtermanCFO Sell Plan 584182,769 held (−0%) $26.74 $16K — —
Nov 28SEC Aby J. MathewEvp & Chief Scientific Officer Sell Plan 526350,386 held (−0%) $26.74 $14K — —
Nov 28SEC Karen A. FosterChief Quality And Operations Sell Plan 415192,838 held (−0%) $26.74 $11K — —
Nov 28SEC Todd BerardChief Marketing Officer Sell Plan 351133,266 held (−0%) $26.74 $9K — —
Nov 28SEC Sarah AebersoldChief Human Resources Officer Sell Plan 21776,952 held (−0%) $26.74 $6K — —
Nov 28SEC Sean WernerCTO Sell Plan 11025,927 held (−0%) $26.74 $3K — —
Nov 21SEC Amy DurossDirector Sell 4,52325,687 held (−15%) $24.51 $111K — —
Nov 21SEC Amy DurossDirector Sell 1,00024,687 held (−4%) $26.00 $26K — —
Nov 21SEC Amy DurossDirector Sell 47730,210 held (−2%) $24.50 $12K — —
Nov 13SEC Greef Roderick DeCEO, President Sell 35,417454,581 held (−7%) $26.15 $926K — —
Nov 13SEC Greef Roderick DeCEO, President Sell 33,418421,163 held (−7%) $25.88 $865K — —
Nov 13SEC Greef Roderick DeCEO, President Sell 31,165389,998 held (−7%) $25.33 $789K — —
Oct 28SEC Joydeep GoswamiDirector Sell Plan 1,66644,986 held (−4%) $28.99 $48K — —
Oct 24SEC Greef Roderick DeCEO, President Sell Plan 37,795489,998 held (−7%) $27.30 $1.0M — —
Oct 22SEC Sean WernerCTO Sell Plan 27526,037 held (−1%) $27.82 $8K — —
Oct 20SEC Joydeep GoswamiDirector Sell Plan 1,33446,652 held (−3%) — $0 — —
Oct 17SEC Casdin Partners Gp, Llc10% Owner Sell 750,0005,957,165 held (−11%) $28.55 $21.4M — 36
Oct 14SEC Troy WichtermanCFO Sell Plan 833183,353 held (−0%) $27.36 $23K — —
Oct 14SEC Aby J. MathewEvp & Chief Scientific Officer Sell Plan 509350,912 held (−0%) $27.36 $14K — —
Oct 14SEC Karen A. FosterChief Quality And Operations Sell Plan 419193,253 held (−0%) $27.36 $11K — —
Oct 14SEC Todd BerardChief Marketing Officer Sell Plan 289133,617 held (−0%) $27.36 $8K — —
Oct 14SEC Sarah AebersoldChief Human Resources Officer Sell Plan 18877,169 held (−0%) $27.36 $5K — —

Insiders at BIOLIFE SOLUTIONS INC

InsiderBoughtSoldLast filingScore
Casdin Partners Master Fund, L.P.10% Owner — $28.1M May 21, 2026 87
Casdin Partners Gp, Llc10% Owner — $21.4M Oct 17, 2025 36
Greef Roderick DeCEO, President — $3.6M Nov 13, 2025 —
Karen A. FosterChief Quality And Operations — $2.1M Mar 31, 2026 —
Troy WichtermanCFO — $873K Mar 5, 2026 —
Amy DurossDirector — $306K Dec 17, 2025 —
Aby J. MathewEvp & Chief Scientific Officer — $65K Mar 5, 2026 —
Joydeep GoswamiDirector — $48K Oct 28, 2025 —
Sarah AebersoldChief Human Resources Officer — $45K Mar 5, 2026 —
Todd BerardChief Marketing Officer — $42K Mar 5, 2026 —
Sean WernerCTO — $13K Mar 5, 2026 —

BLFS stock: common questions

Are BIOLIFE SOLUTIONS INC insiders buying BLFS stock?

In the past 12 months, 0 insiders reported open-market purchases of BLFS worth $0.

Are BIOLIFE SOLUTIONS INC insiders selling BLFS stock?

11 insiders reported sales worth $56.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BLFS's 52-week range?

Over the past year BLFS has traded between $38.61 and $38.61. It last closed at $38.61 on Oct 7, 2026.